Post Profile






PATH and WRAIR announce largest-ever controlled malaria infection

(Burness) PATH's Malaria Vaccine Initiative and the US Department of Defense's Walter Reed Army Institute of Research announced today that vaccinations are under way in a clinical trial to evaluate modifications to the vaccine regimen of GSK's RTS,S/AS01 (RTS,S) malaria vaccine candidate. The partners seek to understand if these modifications will provide equal or increased protection compared to the standard pediatric regimen.
read more

share

Related Posts


Early study shows RTS,S malaria vaccine efficacy may improve by changing dosing schedule

Academics / General Science : Science Codex

SILVER SPRING, MD. - Researchers at the Walter Reed Army Institute of Research (WRAIR) and collaborators recently published results of a phase II study which demonstrated that by changing the dosing regimen, the efficacy of malaria ...

Clinical Trial Of Malaria Vaccine Begins In Africa

Health : Medical News Today

The vaccine, RTS,S, developed by GlaxoSmithKline (GSK) Biologicals and PATH Malaria Vaccine Initiative (MVI), is currently in phase III clinical trials and has previously reduced episodes of malaria in infants and young children by ...

New Therapeutic Vaccine Approach Holds Promise for HIV Remission

Health : Newswise Medical News

A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR), Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Co...

Early study shows RTS,S malaria vaccine efficacy may improve by changing dosing schedule

Academics / Chemistry : EurekAlert: Chemistry

(Walter Reed Army Institute of Research) Researchers at the Walter Reed Army Institute of Research (WRAIR) and collaborators recently published results of a phase II study which demonstrated that by changing the dosing regimen, the ...

First in-human vaccine study for malaria caused by Plasmodium vivax

Academics / General Science : Science Codex

SILVER SPRING, Md. - Walter Reed Army Institute of Research (WRAIR) researchers recently published the results of testing a Plasmodium vivax malaria vaccine candidate in a human challenge model. read more

Comments


Copyright © 2016 Regator, LLC